Sawyers, C
A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing semaglutide and tirzepatide, on average, does not lead to significant weight regain in clinical practice, as many patients later restart the original medication or try an alternative obesity treatment
The latter route has a large advantage of adding circulation time to the drug, allowing long-lasting effects of the drugs, potentially reducing the administration frequency and possibly also lowering gastrointestinal complications, as currently only subcutaneous and very few oral routes have been explored
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R
Speaker: Dr Philippa Hughes (Universitat Rovira i Virgili) 600 How Housing Diversity Affects Urban Residential Segregation: The Tokyo Model A diverse housing supply is widely recognized as a crucial mechanism for mitigating socioeconomic segregation by allowing different income groups to coexist within the same urban fabric
Yes, all of these are subcutaneous injectable medications Patients self-administer the injections, typically once daily (Saxenda) or once weekly (Wegovy, Ozempic, Zepbound) A pharmacist or healthcare provider will teach proper injection technique Dose adjustments should not be done independently
